Equities

Geratherm Medical AG

Geratherm Medical AG

Actions
Health CareMedical Equipment and Services
  • Price (EUR)4.32
  • Today's Change-0.02 / -0.46%
  • Shares traded0.00
  • 1 Year change-41.62%
  • Beta-0.0227
Data delayed at least 15 minutes, as of Mar 28 2024 16:36 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Geratherm Medical AG is a Germany-based medical technology. The Company operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. The Healthcare Diagnostic segment provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. The Medical Warming Systems provides solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. The Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.

  • Revenue in EUR (TTM)25.03m
  • Net income in EUR1.04m
  • Incorporated2000
  • Employees188.00
  • Location
    Geratherm Medical AGFahrenheitstrasse 1GESCHWENDA 99331GermanyDEU
  • Phone+49 9 716991380
  • Fax+49 9 716991382
  • Websitehttps://www.geratherm.de
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nexstim Oyj7.25m-1.33m15.70m37.00--5.53--2.17-0.1956-0.19561.090.41920.72110.27083.76195,845.70-13.21-26.77-20.24-43.9096.3892.11-18.32-38.381.42-12.600.61---23.9422.08-201.58--19.51--
Acousort AB479.54k-1.48m15.88m----7.60--33.12-1.28-1.280.41651.620.14575.102.52---44.97-48.62-79.33-69.77-69.83-68.05-308.76-299.582.76------11.5138.81-24.01------
Acarix AB540.71k-6.74m16.38m9.00--3.64--30.30-0.155-0.1550.01230.07040.09430.15625.90---117.61-66.93-150.10-77.1284.8779.42-1,247.20-1,483.683.95-272.120.00--7.2043.55-1.11------
Seyitler Kimya Sanayi AS4.05m1.06m17.19m63.0016.183.6815.054.240.37090.37091.411.630.7141.737.011,836,392.0018.7336.2022.3544.0238.1239.8626.2343.893.38--0.13190.0084.4045.46193.51107.1230.39--
Theraclion SA1.87m-4.88m17.38m30.00--2.57--9.29-0.1362-0.13620.05040.14810.10210.2821.2366,785.00-26.65-40.08-35.36-59.9654.2152.19-260.94-276.132.50-56.170.2546---16.58-12.66-32.02--11.77--
Episurf Medical AB909.70k-8.21m18.71m28.00--2.56--20.57-0.3551-0.35510.03930.31640.0697--6.36375,000.00-62.95-47.46-70.45-52.01-----903.81-1,019.293.52--0.058--53.6219.78-22.64---0.4158--
Diagnostic Medical Systems SA37.53m3.02m20.08m120.007.201.103.700.53520.15770.02832.171.030.71461.694.58320,760.703.97-11.146.98-19.5239.4937.795.55-15.540.8608-5.700.5059---4.575.40-44.25------
Inspiration Healthcare Group PLC48.07m-643.55k22.75m210.00--0.55211.550.4734-0.0081-0.00810.6030.51630.78792.324.76195,619.00-1.056.14-1.257.6045.5947.42-1.346.001.50-0.12890.2317--0.445821.62-93.58-25.9752.54--
SpectraCure AB (publ)246.31k-1.77m23.14m15.00--2.06--93.95-0.2154-0.21540.031.340.0185--17.28189,533.30-13.31-12.75-14.35-13.62435.56195.30-718.99-494.40----0.0492---3.30--19.46------
Geratherm Medical AG25.03m1.04m23.52m188.0014.361.037.070.93990.30080.30085.434.210.63521.077.37119,744.404.362.535.363.0866.2065.826.863.523.5437.640.2596164.987.984.21737.258.5312.77-20.42
Micropos Medical AB (publ)141.91k-2.04m24.35m4.00--30.27--171.59-0.1663-0.16630.01170.06110.06060.05381.46---87.07-64.24-115.32-82.2786.75114.76-1,437.12-767.581.15--0.0429--50.245.94-26.57------
Ondine Biomedical Inc550.55k-12.81m24.50m43.00--7.46--44.51-0.0562-0.05620.00240.01240.04920.35845.5410,942.24-114.33---135.98--49.00---2,326.12--1.93--0.1961---75.17--61.32------
IMD International Medical Devices SpA-100.00bn-100.00bn24.88m----1.67----------0.8431------------------------0.923--0.1451---9.53---28.78------
Mauna Kea Technologies SA10.90m-2.17m26.36m67.00----24.502.42-0.0488-0.04880.2449-0.33860.52652.016.73194,696.40-2.61-58.19-5.19-83.9137.11-1.33-4.96-182.400.740529.852.22---2.872.2616.85---27.66--
Biocartis Group NV60.61m-67.87m27.24m526.00------0.4493-0.9993-0.99930.8171-0.57480.55481.563.31115,231.90-62.13-34.35-84.71-40.3851.4040.84-111.97-145.711.60-2.551.55--19.0822.368.52---14.81--
Scandinavian Medical Solutions A/S25.63m1.64m28.76m--17.412.8612.361.120.44790.44797.002.731.422.0017.46--9.05--15.48--25.83--6.39--0.406219.960.2776--72.98--7.49------
Data as of Mar 28 2024. Currency figures normalised to Geratherm Medical AG's reporting currency: Euro EUR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.